StockData
ClearPoint Neuro, Inc. logo

ClearPoint Neuro, Inc. (CLPT) stock

CLPTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 4/3012% above fair value
$7.86−0.44 (-5.30%)

Close on Nov 17, 2026Market cap $251.95MP/E –Yield –

ClearPoint Neuro cash

Cash and short-term investments held at the end of each period.

ClearPoint Neuro's cash was $46.18M at Sep 30, 2026. For fiscal 2025 it was $45.92M, up 128.4% from the year before. Over ten years it grew 23.8% a year on average. The highest annual figure on record is $54.11M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$45.92M+128.4%
FY2024Dec 31, 2024$20.10M-13.1%
FY2023Dec 31, 2023$23.14M-38.3%
FY2022Dec 31, 2022$37.49M-30.7%
FY2021Dec 31, 2021$54.11M+169.2%
FY2020Dec 31, 2020$20.10M+252.9%
FY2019Dec 31, 2019$5.70M+83.7%
FY2018Dec 31, 2018$3.10M-66.6%
FY2017Dec 31, 2017$9.29M+180.2%
FY2016Dec 31, 2016$3.32M-38.7%
FY2015Dec 31, 2015$5.41M-41.5%
FY2014Dec 31, 2014$9.24M+162.9%
FY2013Dec 31, 2013$3.52M+117.1%
FY2012Dec 31, 2012$1.62M+1013.6%
FY2011Dec 31, 2011$145.48K-90.8%
FY2010Dec 31, 2010$1.58M-38.6%
FY2009Dec 31, 2009$2.57M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$46.18M+20.8%
Q2 FY2026Jun 30, 2026$29.36M-29.3%
Q1 FY2026Mar 31, 2026$35.59M+187.3%
Q4 FY2025Dec 31, 2025$45.92M+128.4%
Q3 FY2025Sep 30, 2025$38.22M+77.2%
Q2 FY2025Jun 30, 2025$41.54M+26.5%
Q1 FY2025Mar 31, 2025$12.39M-65.0%
Q4 FY2024Dec 31, 2024$20.10M-13.1%
Q3 FY2024Sep 30, 2024$21.57M-11.4%
Q2 FY2024Jun 30, 2024$32.85M+24.1%
Q1 FY2024Mar 31, 2024$35.35M+11.4%
Q4 FY2023Dec 31, 2023$23.14M-38.3%
Q3 FY2023Sep 30, 2023$24.34M-39.8%
Q2 FY2023Jun 30, 2023$26.46M-41.4%
Q1 FY2023Mar 31, 2023$31.74M-36.1%
Q4 FY2022Dec 31, 2022$37.49M-30.7%
Q3 FY2022Sep 30, 2022$40.46M-29.8%
Q2 FY2022Jun 30, 2022$45.14M-26.6%
Q1 FY2022Mar 31, 2022$49.66M-23.4%
Q4 FY2021Dec 31, 2021$54.11M+169.2%
Q3 FY2021Sep 30, 2021$57.65M+293.1%
Q2 FY2021Jun 30, 2021$61.52M+283.8%
Q1 FY2021Mar 31, 2021$64.86M+282.1%
Q4 FY2020Dec 31, 2020$20.10M+252.9%
Q3 FY2020Sep 30, 2020$14.67M+135.2%
Q2 FY2020Jun 30, 2020$16.03M+114.9%
Q1 FY2020Mar 31, 2020$16.98M+581.3%
Q4 FY2019Dec 31, 2019$5.70M+83.7%
Q3 FY2019Sep 30, 2019$6.24M+68.0%
Q2 FY2019Jun 30, 2019$7.46M+11.4%
Q1 FY2019Mar 31, 2019$2.49M-66.8%
Q4 FY2018Dec 31, 2018$3.10M-66.6%
Q3 FY2018Sep 30, 2018$3.71M-66.4%
Q2 FY2018Jun 30, 2018$6.70M+240.0%
Q1 FY2018Mar 31, 2018$7.51M+281.5%
Q4 FY2017Dec 31, 2017$9.29M+180.2%
Q3 FY2017Sep 30, 2017$11.03M–
Q2 FY2017Jun 30, 2017$1.97M–
Q1 FY2017Mar 31, 2017$1.97M–
Q4 FY2016Dec 31, 2016$3.32M–

More ClearPoint Neuro figures

See a number that looks wrong?